Organoids and Spheroids Market

Global Organoids And Spheroids Market by Types (Organoids[Types, Methods, Sources], Spheroids [Types, Methods, Sources]), Applications (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing), End-uses (Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers),and Regions( AsiaPacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2020-2027

  • Report ID: HC-184
  • Author: Growth Market Reports
  • Rating: 4.5
  • Total Reviews: 5
  • No. Of Pages: 156
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global organoids and spheroids market is anticipated to expand at substantial CAGR during the forecast period, between 2020 and 2027. The global organoids and spheroids market is driven by the increase in the demand for cell therapy and tissue engineering. Rising demand for organoid cultures in the drug development process is anticipated to fuel the market during the forecast period. 3D spheroids are considered to be essential aspects in the field of regenerative medicine science and tissue engineering. Organoids and spheroids are majorly used as building blocks in the generation of complex organs and tissues.


Market Trends, Drivers, Restraints, and Opportunities:

  • Rapid technological developments in the 3D spheroid technology are expected to fuel the market growth.
  • Increasing focus of governments and healthcare agencies on cancer has accelerated the metastasization, development, and progression of diseases, thereby boostingmarket growth.
  • Complexity in the reconstruction of complex in vivo cellular diversity and signaling of organs or tumors is expected to hamper the market.


Scope of the report:

Attributes

Details

Base Year

2019

Historic Data

2017 & 2018

Forecast Period

2020–2027

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market Scope, Analysis, Share, Competitive Analysis, Growth Facts, Restraints, Opportunities and Revenue Forecast

The report on the global organoids and spheroids market includes an assessment of the market, size, share, trends, segments and regional markets. Overview and dynamics have been included in the report.


Organoids and Spheroids Market Segment Insights:

Higher demand for spheroidsas compared to organoids
In the terms of types, the market has been bifurcated into organoids and spheroids. These segments are further divided into sub-segments types, methods, and sources. The spheroids segment is projected to grow at significant pace during the forecast period as spheroid culture is widely used in medicinal products, toxicology, and cancer research.

Developmental biology segment held substantial market share in 2019
Based on applications, the market is fragmented into developmental biology, personalized medicine, regenerative medicine, disease pathology studies, and drug toxicity & efficacy testing. The biology development segment constituted a significant share of the market in 2019 due to increasing use of organoid and spheroid culture systems for biological development. The regenerative medicine segment is projected to constitute large market share during the forecast period, as organoid and spheroid transplantation from adult stem cells helps replace the diseased tissue or organ.

Biotechnology and pharmaceutical industries segment accounts for significant market share
On the basis of end-uses, the organoids and spheroids market has been segregated into biotechnology and pharmaceutical industries, academic & research institutes, and hospitals and diagnostic centers. The biotechnology and pharmaceutical industries segment is projected to expand at a significant pace during the forecast period. Potential organoid and spheroid clinical applications have encouraged pharmaceutical start-ups to enter this market. Furthermore, high consumption of organoids and spheroids in pre-clinical drug discovery by pharmacists is expected to boost segment growth.

North America constituted a dominant share of the global market
Based on regions, the global organoids and spheroids market is segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the global organoids and spheroids market. The region accounted for a significant share of the market in 2019due to an increase in organoid-based models of biotechnology and spheroid research in the US and Canada. The market in Asia Pacific is anticipated to expand at a substantial pace during the forecast period due to the rise in partnerships among key market players and constant developments in the field of stem cells research.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Organoids and Spheroids Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Organoids and Spheroids Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Organoids and Spheroids Market - Supply Chain
  4.5. Global Organoids and Spheroids Market Forecast
     4.5.1. Organoids and Spheroids Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Organoids and Spheroids Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Organoids and Spheroids Market Absolute $ Opportunity
5. Global Organoids and Spheroids Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Organoids and Spheroids Market Size and Volume Forecast by Types
     5.3.1. Biotechnology and Pharmaceutical Industries
     5.3.2. Academic & Research Institutes
     5.3.3. Hospitals and Diagnostic Centers
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Organoids and Spheroids Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Organoids and Spheroids Market Size and Volume Forecast by Applications
     6.3.1. Developmental Biology
     6.3.2. Personalized Medicine
     6.3.3. Regenerative Medicine
     6.3.4. Disease Pathology Studies
     6.3.5. Drug Toxicity & Efficacy Testing
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Organoids and Spheroids Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Organoids and Spheroids Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Organoids and Spheroids Demand Share Forecast, 2019-2026
8. North America Organoids and Spheroids Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Organoids and Spheroids Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Organoids and Spheroids Market Size and Volume Forecast by Types
     8.4.1. Biotechnology and Pharmaceutical Industries
     8.4.2. Academic & Research Institutes
     8.4.3. Hospitals and Diagnostic Centers
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Organoids and Spheroids Market Size and Volume Forecast by Applications
     8.7.1. Developmental Biology
     8.7.2. Personalized Medicine
     8.7.3. Regenerative Medicine
     8.7.4. Disease Pathology Studies
     8.7.5. Drug Toxicity & Efficacy Testing
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Organoids and Spheroids Demand Share Forecast, 2019-2026
9. Latin America Organoids and Spheroids Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Organoids and Spheroids Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Organoids and Spheroids Market Size and Volume Forecast by Types
     9.4.1. Biotechnology and Pharmaceutical Industries
     9.4.2. Academic & Research Institutes
     9.4.3. Hospitals and Diagnostic Centers
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Organoids and Spheroids Market Size and Volume Forecast by Applications
     9.7.1. Developmental Biology
     9.7.2. Personalized Medicine
     9.7.3. Regenerative Medicine
     9.7.4. Disease Pathology Studies
     9.7.5. Drug Toxicity & Efficacy Testing
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Organoids and Spheroids Demand Share Forecast, 2019-2026
10. Europe Organoids and Spheroids Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Organoids and Spheroids Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Organoids and Spheroids Market Size and Volume Forecast by Types
     10.4.1. Biotechnology and Pharmaceutical Industries
     10.4.2. Academic & Research Institutes
     10.4.3. Hospitals and Diagnostic Centers
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Organoids and Spheroids Market Size and Volume Forecast by Applications
     10.7.1. Developmental Biology
     10.7.2. Personalized Medicine
     10.7.3. Regenerative Medicine
     10.7.4. Disease Pathology Studies
     10.7.5. Drug Toxicity & Efficacy Testing
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Organoids and Spheroids Demand Share Forecast, 2019-2026
11. Asia Pacific Organoids and Spheroids Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by Types
     11.4.1. Biotechnology and Pharmaceutical Industries
     11.4.2. Academic & Research Institutes
     11.4.3. Hospitals and Diagnostic Centers
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Organoids and Spheroids Market Size and Volume Forecast by Applications
     11.7.1. Developmental Biology
     11.7.2. Personalized Medicine
     11.7.3. Regenerative Medicine
     11.7.4. Disease Pathology Studies
     11.7.5. Drug Toxicity & Efficacy Testing
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Organoids and Spheroids Demand Share Forecast, 2019-2026
12. Middle East & Africa Organoids and Spheroids Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by Types
     12.4.1. Biotechnology and Pharmaceutical Industries
     12.4.2. Academic & Research Institutes
     12.4.3. Hospitals and Diagnostic Centers
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Organoids and Spheroids Market Size and Volume Forecast by Applications
     12.7.1. Developmental Biology
     12.7.2. Personalized Medicine
     12.7.3. Regenerative Medicine
     12.7.4. Disease Pathology Studies
     12.7.5. Drug Toxicity & Efficacy Testing
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Organoids and Spheroids Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Organoids and Spheroids Market: Market Share Analysis
  13.2. Organoids and Spheroids Distributors and Customers
  13.3. Organoids and Spheroids Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

By Types

  • Orgonoids
    • By Types
      • Neural Organoids
      • Hepatic Organoids
      • Intestinal Organoids
      • Other Organoids
    • By Methods
      • General Submerged Method for Organoid Culture
      • Crypt Organoid Culture Techniques
      • Air Liquid Interface (ALI) Method for Organoid Culture
      • Clonal Organoids from Lgr5+
      • Brain and Retina Organoid Formation Cells Protocol
    • By Sources
      • Primary Tissues
      • Stem Cells
  • Spheroids
    • By Types
      • Multicellular Tumor Spheroids (MCTS)
      • Neurospheres
      • Mammospheres
      • Hepatospheres
      • EmbryoidBodies
    • By Methods
      • Micropatterned Plates
      • Low Cell Attachment Plates
      • Hanging Drop Method
      • Others
    • By Sources
      • Cell Line
      • Primary Cell
      • iPSCs Derived Cells
By Applications
  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing
By End-uses
  • Biotechnology and Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

 

Some of the key players in the global organoids and spheroids market include 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology (Europe) Limited, ATCC, Cellesce Ltd., Corning Incorporated, Greiner Bio-One, HubrechtOrganoid Technology (HUB), InSphero/Perkin Elmer, Kuraray, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc., and Thermo Fisher Scientific, Inc. Mergers & acquisitions, collaborations, agreements, and partnerships are some strategies adopted by these players to strengthen their geographical presence.

Buy Report